Vertical: CNMBase Year: 2025
Market Size (2025)
$102.63M
Projected (2032)
$139.31M
CAGR (2022–2032)
4.5%
Key Players
11+
Market Overview
The global L-threonine market was valued at USD 102.63 Million in 2025 and is projected to reach USD 139.31 Million by 2032, registering a CAGR of 4.46% over 2026–2032. The market has expanded steadily from USD 90.00 Million in 2022, and the forecast period is expected to add USD 36.68 Million in absolute value between 2025 and 2032. L-threonine is the third limiting essential amino acid in typical cereal-based swine diets and the second or third limiting amino acid in poultry diets, which makes it a core component of the feed-grade amino acid basket alongside L-lysine and DL-methionine.
Demand is driven primarily by the compound feed industry, where crystalline L-threonine allows nutritionists to formulate diets on a standardised ileal digestible amino acid basis, lower crude protein levels and reduce dependence on soybean meal. Growth over the forecast period is supported by rising meat and egg consumption in emerging economies, the wider adoption of low-protein diet programmes, tightening nitrogen-emission rules in livestock production, and the continued shift from backyard to commercial, integrated farming. Supply is highly concentrated: fermentation capacity is located predominantly in China, and the industry has gone through a period of capacity additions, softer prices and trade-policy scrutiny of Chinese amino acid exports.
Key Findings
By Livestock: Swine is the largest segment, accounting for 50.0% of the market in 2025 (USD 51.31 Million). The Others segment is the fastest-growing, with a CAGR of 5.61% over 2026–2032, while Poultry, at a CAGR of 5.11%, adds the largest absolute value among all livestock segments.
By Physical Form: Powder & Granules dominates with a 95.0% share in 2025 (USD 97.50 Million). The Others segment is the fastest-growing form, with a CAGR of 6.15%.
By Region: Asia Pacific is the leading region with a 42.0% share in 2025 (USD 43.10 Million). Middle East & Africa is the fastest-growing region, with a CAGR of 5.19%, followed closely by Asia Pacific at 5.05%.
By Country: China is the leading country market, valued at USD 25.00 Million in 2025 and expected to reach USD 33.60 Million by 2032. India is the fastest-growing country, with a CAGR of 8.33% over 2026–2032.
Segmentation Summary
By Livestock, the market is segmented into Swine, Poultry and Others. Swine is the largest segment, valued at USD 51.31 Million in 2025 and forecast to reach USD 66.31 Million by 2032 at a CAGR of 3.73%; threonine requirements are high in pig diets because of the amino acid's role in intestinal mucin synthesis and immune function, particularly in piglet and grower feeds. Poultry, valued at USD 46.18 Million in 2025, is projected to reach USD 65.48 Million by 2032 at a CAGR of 5.11%, nearly closing the gap with swine as broiler and layer production expands across Asia, Latin America and the Middle East. The Others segment, covering species such as aquaculture, ruminants, pets and other animals, is the smallest at USD 5.13 Million in 2025 but is the fastest-growing at a CAGR of 5.61%.
By Physical Form, Powder & Granules accounts for the overwhelming majority of demand, at USD 97.50 Million in 2025, rising to USD 131.51 Million by 2032 at a CAGR of 4.37%. Feed-grade L-threonine (typically 98.5% purity) is traded mainly as a free-flowing crystalline powder or granulate suited to premix and compound-feed plants. Other forms, valued at USD 5.13 Million in 2025, are expected to grow at a CAGR of 6.15% to reach USD 7.80 Million by 2032, reflecting interest in alternative product presentations for specific handling and dosing systems.
By Region, Asia Pacific (USD 43.10 Million in 2025) leads the market and is projected to reach USD 60.88 Million by 2032. North America and Europe are each valued at USD 18.47 Million in 2025 and grow at a CAGR of 3.43%, reflecting mature livestock sectors where threonine inclusion is already well established. Latin America (USD 16.42 Million in 2025, CAGR 4.83%) benefits from export-oriented poultry and pork production, while Middle East & Africa (USD 6.16 Million in 2025, CAGR 5.19%) is the fastest-growing region from a smaller base.
Competitive Landscape Summary
The L-threonine industry is moderately consolidated at the producer level and dominated by large-scale fermentation companies in China. Meihua Holdings Group, Fufeng Group and Guangdong Xinghu Technology (through Ningxia Eppen Biotech) are the leading Chinese producers, while CJ CheilJedang (CJ BIO) operates the most geographically diversified production network, with threonine output in China, the United States and Brazil. Evonik Industries supplies its ThreAMINO brand through a toll-manufacturing model, and a group of second-tier Chinese producers, including Heilongjiang Chengfu, Suihua Xiangyu, Shouguang Juneng Golden Corn, Anhui Fengyuan (BBCA) and Global Bio-Chem Technology, adds further capacity. Competition is driven largely by cost position, corn and energy input costs, fermentation yields, logistics and access to export markets. Recent strategic activity includes large capacity projects in north-east China, Fufeng's first production base outside China in Kazakhstan, Meihua's acquisition of Kyowa Hakko Bio's amino acid business and CJ CheilJedang's decision to retain and restructure its BIO division.
Challenges and Opportunities
The principal challenges for the market are the cyclical oversupply of fermentation capacity, which has depressed threonine prices since 2023, the dependence of global supply on a single producing country, exposure to corn, sugar and energy price volatility, and the growing use of trade-defence instruments against Chinese amino acids in the European Union and the United States. Animal disease outbreaks such as African swine fever and highly pathogenic avian influenza also create periodic demand shocks in the two largest livestock segments.
Opportunities are linked to the structural move towards low-protein, amino acid-balanced diets, policy programmes to reduce soybean meal use in feed, the expansion of commercial poultry and swine production in South and Southeast Asia, Latin America and Africa, and new applications in aquafeed and pet food. Producers that diversify production geographically, improve strain productivity and offer higher-value product formats are positioned to capture a larger share of incremental demand.
Future Outlook
The market is expected to grow at a steady CAGR of 4.46% over 2026–2032, reaching USD 139.31 Million by 2032. Asia Pacific will remain the centre of both demand and supply, accounting for USD 17.77 Million of the USD 36.68 Million absolute growth between 2025 and 2032. Poultry is projected to account for the largest share of incremental demand among livestock segments, adding USD 19.29 Million over the same period. Over the medium term, supply-side discipline, trade measures and the pace of low-protein diet adoption in China and other high-volume feed markets will be the key variables shaping market value.
The L-Threonine Market market is projected to grow at a CAGR of 4.5% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
L-threonine ((2S,3R)-2-amino-3-hydroxybutanoic acid, C4H9NO3, CAS No. 72-19-5) is an essential, hydroxyl-containing alpha-amino acid that animals cannot synthesise and must obtain from the diet. It is a major constituent of intestinal mucin proteins and immunoglobulins, and it participates in protein synthesis, gut barrier maintenance and immune response. In practical cereal–soybean meal diets, threonine is typically the third limiting amino acid for pigs (after lysine and methionine) and among the first limiting amino acids for poultry, so crystalline L-threonine is added to feed to meet requirements precisely without raising dietary crude protein.
Commercial L-threonine is produced almost entirely by aerobic microbial fermentation, using engineered strains of Escherichia coli or Corynebacterium glutamicum and carbohydrate feedstocks such as corn-derived glucose or sugar. The fermentation broth is purified through separation, crystallisation and drying to produce a feed-grade product with a minimum L-threonine content of about 98.5%, alongside smaller volumes of food- and pharmaceutical-grade material.
Included in the scope: L-threonine in all purities and grades supplied for use in animal nutrition, in powder and granular form as well as other physical forms, sold to compound feed manufacturers, premix producers, integrators and livestock farms for swine, poultry and other animals. Excluded from the scope: other feed amino acids such as L-lysine, DL-methionine, L-tryptophan and L-valine; threonine contained naturally in feed ingredients such as soybean meal; and compound feeds or premixes in which L-threonine is only one ingredient, except for the value of the L-threonine they contain.
Scope of the Study
The study covers the global L-threonine market and analyses it by livestock, physical form and region. The regional analysis covers North America, Europe, Asia Pacific, Latin America and Middle East & Africa, together with the countries within each region listed in the market structure below. Market values are presented for the historic period 2022–2024, the base year 2025 and the forecast period 2026–2032. All values are expressed in USD Million, and growth rates are presented as compound annual growth rates (CAGR) for 2026–2032.
Research Objectives
To define, describe and quantify the global L-threonine market by livestock, physical form and region for 2022–2032.
To estimate the size of the market in the base year 2025 and forecast its value up to 2032, with CAGR for the 2026–2032 period.
To analyse the role of L-threonine in swine, poultry and other animal diets and assess how low-protein diet strategies and soybean meal reduction programmes affect demand.
To identify and assess the key drivers, restraints, opportunities, trends and challenges shaping the market, including fermentation capacity cycles and trade-policy developments.
To examine the value chain from carbohydrate feedstocks and fermentation to distribution and end use, and to evaluate the competitive intensity of the industry using Porter's Five Forces.
To analyse the market across five regions and their constituent countries, highlighting demand drivers, livestock production trends and regulatory conditions.
To profile the competitive landscape, including the positioning of leading producers and their key developments since 2022.
To provide strategic insight into growth pockets by segment, region and country for producers, distributors, feed manufacturers and investors.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured, multi-stage research process combining secondary research, primary research and analytical modelling. The process began with defining the market and its segmentation, followed by extensive desk research to build an understanding of L-threonine production technology, feed formulation practices, livestock production trends and the competitive landscape. Preliminary market estimates were then developed through top-down and bottom-up models, validated through discussions with industry participants across the value chain, and finalised through data triangulation. The final step involved forecasting market values for 2026–2032 and conducting quality checks for internal consistency across segments, regions and countries.
Secondary Research
Secondary research was used to collect information on market size, production capacity, livestock and feed output, trade flows, pricing and regulation. Key source types relevant to the L-threonine industry include:
Industry associations: feed manufacturing and animal nutrition associations such as the International Feed Industry Federation, FEFAC (European Feed Manufacturers' Federation), FEFANA (EU Association of Specialty Feed Ingredients and their Mixtures), the American Feed Industry Association and the China Feed Industry Association.
Government and regulatory bodies: agriculture ministries, livestock statistics agencies, customs authorities and feed-additive regulators, including the USDA, the US FDA Center for Veterinary Medicine, the European Commission and EFSA, China's Ministry of Agriculture and Rural Affairs and General Administration of Customs, and Brazil's Ministry of Agriculture and Livestock.
Company filings: annual reports, interim results, stock exchange announcements, investor presentations and press releases of amino acid producers and feed companies.
Trade journals and publications: animal nutrition and feed industry publications, scientific journals on amino acid nutrition and fermentation technology, and EFSA FEEDAP scientific opinions on L-threonine production strains.
Paid databases: trade statistics databases, company financial databases and commodity price-reporting services covering feed amino acids, corn and soybean meal.
Primary Research
Primary research was conducted to validate secondary findings, fill information gaps and obtain qualitative insight into market dynamics. Interviews were carried out with participants on both the supply and demand sides of the market.
Supply side: executives and managers at L-threonine producers, including business development, sales, marketing and production functions; amino acid distributors and traders; and premix manufacturers.
Demand side: nutritionists and procurement managers at compound feed manufacturers, integrated poultry and swine producers, and other animal feed manufacturers, as well as independent animal nutrition consultants.
Objectives: to validate market size and segment splits, understand inclusion rates and formulation practices, assess pricing trends and purchasing behaviour, identify regional demand drivers, and gather views on capacity developments, trade measures and the market outlook.
Market Size Estimation
Top-down approach: The global feed amino acid market and global compound feed production were used as the starting point. The share of L-threonine within the feed amino acid basket was estimated and then allocated across regions, countries, livestock categories and physical forms using production statistics, feed output data and industry input.
Bottom-up approach: Country-level demand was estimated from compound feed production by livestock type, typical L-threonine inclusion rates in swine, poultry and other feeds, and the degree of amino acid supplementation in each market. Values were derived by applying regional average selling prices, and country estimates were aggregated to regional and global totals.
Data triangulation: The outputs of the top-down and bottom-up approaches were compared and reconciled with supply-side information, including producer capacity, utilisation and export data. Differences were resolved through further analysis and primary interviews to arrive at final market estimates.
Forecasting Methodology
Forecasts for 2026–2032 were developed using a combination of trend analysis and driver-based modelling. Factors considered include projected swine and poultry production, compound feed output, adoption of low-protein diets and soybean meal reduction policies, changes in inclusion rates, price trends for L-threonine and its feedstocks, capacity additions, trade measures and regulatory developments. Historic growth patterns for 2022–2024 and the base-year position in 2025 were used to calibrate the model, and segment, regional and country forecasts were reconciled with the global total.
Assumptions and Limitations
Market values are based on manufacturer-level selling prices and are expressed in nominal USD; the effects of currency fluctuations are not separately modelled.
The forecast assumes no major, prolonged disruption to global livestock production beyond the disease cycles already observed, and no structural change in feed formulation practices beyond the trends described in this report.
Trade-defence measures in force at the time of the study are assumed to remain in place over their stated duration; new measures specifically targeting L-threonine are not assumed.
Corn, sugar and energy prices are assumed to follow broadly stable long-term trends, although short-term volatility may affect annual market values.
Official trade statistics record L-threonine under broader customs classifications, which limits the precision of trade-based cross-checks.
Information on privately held and smaller producers is limited, and estimates for these companies rely on industry interviews and secondary sources.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global L-threonine market is moderately consolidated at the production level. A small number of large fermentation companies, most of them based in China, account for the majority of global capacity, and the leading three to five Chinese producers control a large share of Chinese output. Outside China, CJ CheilJedang is the only producer with a multi-country threonine manufacturing footprint, while Evonik Industries markets threonine produced under a toll-manufacturing arrangement. Several Western producers have reduced their exposure to the product: Evonik closed its Hungarian threonine facility in 2018, and ADM halted feed-grade threonine production in the first half of 2023, citing market conditions and global overcapacity.
Competition is primarily price-based because feed-grade L-threonine is a standardised commodity sold to large, price-sensitive feed manufacturers. Key competitive factors include feedstock cost and integration into corn processing, fermentation yield and energy efficiency, scale, access to export markets and distribution networks, regulatory authorisations in destination markets and the ability to supply a broad amino acid portfolio. In recent years, competitive strategy has centred on capacity expansion in low-cost locations in north-east China, geographic diversification to manage trade-policy risk, portfolio restructuring and the development of value-added product formats.
Key Player Positioning
Meihua Holdings Group is the largest threonine producer in China, with major fermentation bases in Inner Mongolia and Xinjiang, and is expanding further with a new threonine project at Tongliao. Its 2025 acquisition of Kyowa Hakko Bio's amino acid business, now operating as Plumino, extends its reach into pharmaceutical-grade amino acids. Fufeng Group is a leading producer of lysine, threonine and other feed amino acids, operates at full utilisation and is building its first overseas base in Kazakhstan. Guangdong Xinghu Technology, through Ningxia Eppen Biotech, is another top-tier Chinese producer and has approved a large amino acid project in Daqing, Heilongjiang, that includes feed-grade threonine. CJ CheilJedang describes its BIO division as the world's largest producer of feed amino acids and produces threonine in China, the United States and Brazil.
Threat of New Entrants – Low
Large-scale fermentation plants require substantial capital investment and access to competitive feedstock, energy and utilities.
Proprietary high-yield production strains, process know-how and regulatory authorisations, such as strain-specific EU feed-additive approvals, act as barriers.
Persistent overcapacity and low prices reduce the attractiveness of new entry.
Bargaining Power of Suppliers – Medium
Corn, glucose and energy are widely available commodities, but their prices are volatile and difficult to hedge fully.
Many leading producers are integrated into corn processing, reducing their dependence on external suppliers.
Specialised equipment and strain technology providers have some influence but represent a limited share of costs.
Bargaining Power of Buyers – High
Large feed manufacturers and integrators purchase in significant volumes and use competitive tenders.
Feed-grade L-threonine is a standardised product, and buyers can switch suppliers with limited cost.
Excess supply since 2023 has strengthened buyers' negotiating positions on price.
Threat of Substitutes – Low to Medium
There is no direct chemical substitute for L-threonine in meeting the animal's threonine requirement.
Formulators can partly offset crystalline threonine with higher inclusion of intact protein sources such as soybean meal when amino acid prices are high.
This substitution raises crude protein, feed cost and nitrogen excretion, limiting its attractiveness.
Competitive Rivalry – High
A small number of large producers compete intensively on price for global export volumes.
Capacity additions have run ahead of demand growth, intensifying competition.
Producers compete through cost leadership, geographic diversification, service and product formats.
Threat of New Entrants: Low.
Bargaining Power of Suppliers: Medium.
Bargaining Power of Buyers: High.
Threat of Substitutes: Low to Medium.
Competitive Rivalry: High.
Market estimates by geography (2032)
InsightAsia Pacific leads with $60.88M by 2032, while Middle East & Africa is projected to grow fastest at a 5.5% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $17.01M | $19.78M | $23.40M | 3.2% | 17% |
| Europe | $17.10M | $19.78M | $23.40M | 3.2% | 17% |
| Asia Pacific | $36.72M | $47.58M | $60.88M | 5.2% | 44% |
| Latin America | $14.04M | $18.05M | $22.85M | 5.0% | 16% |
| Middle East & Africa | $5.13M | $6.82M | $8.78M | 5.5% | 6% |
| Total | $90.00M | $112.00M | $139.31M | 4.5% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$139.31M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Swine | $66.31M | 3.7% | 48% |
| Poultry | $65.48M | 5.2% | 47% |
| Others | $7.52M | 5.7% | 5% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on L-Threonine Market covering market dynamics, competitive landscape, and strategic outlook.
The L-Threonine Market market is projected to reach $139.31M by 2032, growing at 4.5% CAGR. The Swine segment holds the largest share.
The L-threonine market is shaped by the interaction of livestock production trends, feed formulation science, fermentation economics and trade policy. On the demand side, the market is tied closely to the volume of industrially produced swine and poultry feed and to the degree to which nutritionists use crystalline amino acids to reduce dietary crude protein. On the supply side, the market is characterised by large-scale, capital-intensive fermentation plants concentrated in China, whose capacity cycles strongly influence global prices. This chapter assesses the macro and micro factors affecting the market, followed by the key drivers, restraints, opportunities, trends and challenges.
Market Growth Factor Analysis
The table below summarises five macroeconomic and five microeconomic factors influencing the L-threonine market, together with the nature of their impact and an impact score out of 10 for three forecast sub-periods. The impact scores are analyst assessments based on the secondary and primary research conducted for this study, where a higher score indicates a stronger influence on market growth in the stated direction.
Shift Towards Low-Protein, Amino Acid-Balanced Diets
The most important structural driver of L-threonine demand is the move from formulating feeds on crude protein to formulating them on digestible essential amino acids. When nutritionists lower the crude protein content of swine and poultry diets, the supply of threonine from intact protein sources such as soybean meal falls, and crystalline L-threonine becomes necessary to keep the diet balanced. Each step down in crude protein therefore raises threonine inclusion, often together with lysine, methionine, tryptophan and valine. Low-protein diets have been shown to maintain performance while reducing feed cost, nitrogen excretion and the incidence of post-weaning diarrhoea in piglets. As feed companies in Asia, Latin America and Africa adopt the formulation practices already standard in Europe and North America, the number of feeds supplemented with L-threonine and the average inclusion rate per tonne of feed both rise, supporting volume growth above the growth rate of compound feed output.
Policy Support for Soybean Meal Reduction
Government policy in major feed-producing countries is increasingly encouraging the reduction of soybean meal use in animal feed, which directly favours synthetic amino acids. China, the world's largest feed producer and soybean importer, has promoted soybean meal reduction for several years. In April 2023, the Ministry of Agriculture and Rural Affairs issued a three-year action plan aiming to lower the share of soybean meal in feed to below 13% by 2025, from 14.5% in 2022, and in 2025 it issued a feed grain-saving implementation plan targeting a further reduction to around 10% by 2030. Achieving these targets at scale requires precise supplementation with crystalline lysine, methionine, threonine and other amino acids. Similar objectives of reducing protein import dependence and improving feed efficiency are present in the European Union's protein strategy discussions and in national feed programmes elsewhere, creating a supportive policy environment for L-threonine over the forecast period.
Growth in Global Poultry and Pork Production
Swine and poultry together account for the vast majority of L-threonine consumption, so demand follows the trajectory of pork, chicken meat and egg production. Poultry is the fastest-expanding meat category globally, supported by its low production cost, short production cycle and broad cultural acceptance, and it is growing particularly quickly in South and Southeast Asia, Latin America, the Middle East and Africa. Pork production remains dominated by China, the European Union, the United States and Brazil, with Chinese herd modernisation after African swine fever accelerating the shift towards large commercial farms that use complete compound feeds. Rising incomes and urbanisation in emerging markets continue to lift per-capita protein consumption, and the expansion of commercial broiler, layer and pig operations in these markets is expected to add new demand for feed amino acids throughout the forecast period.
Environmental Regulation and Sustainability Targets
Livestock production is under increasing regulatory and corporate pressure to reduce nitrogen and ammonia emissions, water pollution from manure and the land-use footprint of feed. Reducing dietary crude protein with crystalline amino acids is one of the most cost-effective ways to lower nitrogen excretion, and reductions of this kind are recognised in environmental guidance for intensive livestock in the European Union and in national nutrient-management frameworks. In addition, food companies and integrators are setting greenhouse gas reduction targets across their supply chains, and lower soybean meal use reduces the embedded emissions associated with imported protein crops. These sustainability objectives reinforce the economic case for L-threonine supplementation, particularly in high-density livestock regions in Europe and Asia.
Expansion in Emerging Livestock Markets
India, Southeast Asia, Africa and parts of the Middle East are moving from backyard and semi-commercial livestock production to integrated, feed-intensive operations. Amino acid supplementation rates in these markets are still below those in Europe and North America, offering scope for both volume growth and higher inclusion rates as nutrition practices converge.
Geographic Diversification of Production
Trade measures and buyers' interest in supply security create opportunities for production outside China. Examples include CJ CheilJedang's threonine output in the United States and Brazil and Fufeng Group's new production base in Kazakhstan, whose first phase is intended mainly to produce threonine and other amino acids for the European market.
New Applications and Value-Added Formats
Aquafeed, pet food, calf milk replacers and specialty feeds offer higher-value outlets for L-threonine. Product developments such as higher-concentration granular formats, dust-free presentations and blends with other amino acids allow suppliers to differentiate in a largely commoditised market.
Overcapacity and Price Volatility
Large capacity additions by Chinese producers have created a structural surplus in L-threonine supply. Industry price indicators show that average threonine prices have trended downwards since 2023, falling further in 2025 and the first half of 2026 as new lines came on stream. Price weakness compresses market value even when volumes grow, reduces margins for producers and has led to production curtailments; ADM, for example, halted feed-grade threonine production in the first half of 2023, citing market conditions and global overcapacity. Continued capacity investment in north-east China may prolong periods of price pressure during the forecast period.
Supply Concentration and Trade-Policy Risk
The overwhelming majority of global L-threonine capacity is located in China, exposing the market to policy, logistics and geopolitical risk. Trade-defence activity against Chinese amino acids has intensified: the European Union imposed definitive anti-dumping duties on lysine from China in July 2025 and on valine in February 2026, and the United States reached final affirmative anti-dumping and countervailing duty determinations on Chinese L-lysine in July 2026. Although these measures do not currently cover threonine, they signal heightened scrutiny of the sector and encourage buyers to diversify supply, which can raise costs for feed manufacturers in import-dependent regions.
Feedstock and Energy Cost Exposure
Fermentation-based production depends on carbohydrate feedstocks, mainly corn-derived glucose, as well as on ammonia, steam and electricity. Fluctuations in corn prices, energy tariffs and environmental compliance costs directly affect production costs, and because threonine is sold into a price-sensitive commodity feed market, producers cannot always pass these costs on to customers.
Challenge: Margin Pressure in a Commodity Market
Because feed-grade L-threonine is largely undifferentiated, competition is primarily on price. Producers must continuously improve strain yields, energy efficiency and by-product utilisation to remain profitable, and smaller or older plants are at risk of curtailment during price downturns.
Challenge: Animal Disease and Demand Volatility
Outbreaks of African swine fever and highly pathogenic avian influenza can cause sudden reductions in herd and flock sizes, disrupting feed demand and trade. The resulting volatility complicates production planning for amino acid suppliers and can delay investment decisions in affected regions.
Trend: Consolidation and Portfolio Restructuring
The industry is undergoing restructuring as companies reassess their position in feed amino acids. Meihua Holdings Group acquired Kyowa Hakko Bio's amino acid business in 2025, CJ CheilJedang ran a sale process for its BIO division before deciding in April 2025 to retain it and subsequently announced a restructuring of the segment, and Evonik reorganised its animal nutrition business in 2023 to separate cost-focused amino acids from specialty nutrition.
Trend: Precision Nutrition and Expanded Amino Acid Use
Feed formulation is moving towards precision nutrition, using ingredient analysis, near-infrared spectroscopy and phase-feeding programmes to match amino acid supply to animal requirements. This increases the use of a wider portfolio of crystalline amino acids, including threonine, valine, isoleucine and tryptophan, and supports greater threonine inclusion in diets for young and immune-challenged animals.
The L-threonine value chain comprises four principal stages, from carbohydrate feedstocks to the livestock producers that ultimately consume the product in feed.
L-threonine for animal nutrition is regulated as a feed additive or feed ingredient in all major markets. Regulatory frameworks govern product authorisation, production strain safety, labelling and quality standards, while trade measures on related amino acids affect market access.
Aug 2022: CJ CheilJedang; Expansion; Announced a USD 210 million investment to expand production of non-lysine amino acids at its plant in Brazil.
Nov 2022: Guangdong Xinghu Technology; Acquisition; Completed the acquisition of 99.22% of Ningxia Eppen Biotech, a major producer of lysine, threonine and other amino acids.
Feb 2023: Fufeng Group; Project Termination; Planned corn milling project in Grand Forks, North Dakota, was terminated after national-security concerns were raised.
Apr 2023: Evonik Industries; Restructuring; Announced the reorganisation of its animal nutrition business into a cost-focused essential amino acids business and a specialty nutrition business.
2023: Meihua Holdings Group; Capacity Expansion; Brought a new threonine production line at Tongliao, Inner Mongolia, into operation.
2024: Fufeng Group; Capacity Expansion; Commissioned an additional 20,000 tonnes of annual threonine capacity.
Sep 2024: CJ CheilJedang; Product Launch; Completed the transition of its granular Thr Pro product from 80% to 85% active L-threonine at Fort Dodge, Iowa.
Nov 2024: Meihua Holdings Group; Acquisition; Agreed to acquire the amino acid and human milk oligosaccharide business of Kyowa Hakko Bio from Kirin Holdings.
Dec 2024: Global Bio-Chem Technology Group; Divestment; Disposed of Changchun Dacheng Industrial and its subsidiaries.
Apr 2025: CJ CheilJedang; Strategic Decision; Called off the planned sale of its BIO division and decided to retain and develop the business.
Apr 2025: Fufeng Group; Expansion; Began construction of an amino acid plant in the Zhambyl region of Kazakhstan, whose first phase is intended mainly to produce threonine and other amino acids for Europe.
Jun 2025: Guangdong Xinghu Technology; Expansion; Approved a 450,000 tonnes per year amino acid project in Daqing, Heilongjiang, including 200,000 tonnes per year of feed-grade threonine.
Jul 2025: Meihua Holdings Group; Acquisition; Completed the acquisition of Kyowa Hakko Bio's amino acid business, which now operates as Plumino.
Feb 2026: CJ CheilJedang; Restructuring; Announced plans to restructure its BIO segment following lower profitability in 2025.
Mar 2026: Fufeng Group; Production Start; Produced the first commercial batches of amino acids at its Kazakhstan plant.
2026: Meihua Holdings Group; Capacity Expansion; A 300,000 tonnes per year threonine project at Tongliao is scheduled to begin production in the second half of 2026.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 30 companies operating in the L-Threonine Market market, including revenue, employee count, and market positioning where available.
Showing 30 of 30 companies
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
Nippon Soda is a mid-cap, diversified Japanese chemical group founded in 1920 as a chlor-alkali producer and progressively re-shaped into a portfolio anchored by two high-value franchises: research-based crop protection (Agri Business, 35% of FY3/26 sales) and specialty "Chemical Materials" (25%), complemented by lower-margin but stable trading/logistics, plant engineering and environmental-recycling businesses. Its crown jewels are niche, high-barrier products in which it holds globally relevant positions — the pharmaceutical excipient NISSO HPC (hydroxypropyl cellulose), liquid polybutadiene NISSO-PB for AI-server copper-clad laminates, KrF photoresist polymer VP-POLYMER, and proprietary agrochemicals such as Mospilan (acetamiprid) and Topsin-M. With FY3/26 net sales of JPY 152.1 billion, record net profit of JPY 18.3 billion, an equity ratio of ~66.6%, and a 50%+ total shareholder return policy, the company is a conservatively financed, R&D-led specialty player now pivoting toward healthcare (including animal health) and advanced ICT materials under its Stage III plan to FY3/30. --- ### Company's own description According to its Stage III medium-term plan (May 2026), Nippon Soda describes its mission as creating new value through the power of chemistry, and frames the group as supporting everyday life through chemical products and services across four "material" fields: Agriculture (securing food and sustainable agriculture), Healthcare (healthy life for all people), Environment (toward a resource-recycling society) and ICT (chemical functions for IT devices). The Yuho describes the parent's business as manufacturing, processing and marketing of industrial chemicals, synthetic resins and plastics, dyes, pharmaceuticals, agrochemicals, veterinary pharmaceuticals and other chemical products. ### Business model and revenue model Nippon Soda's revenue is overwhelmingly product-based (manufactured chemical sales), with secondary service revenues from logistics (warehousing, transport, customs brokerage), engineering/EPC contracts and waste treatment. There is no material subscription revenue. Licensing/active-ingredient supply is embedded in Agri Business: the company supplies proprietary active ingredients (AIs) to global majors and sells formulated products through its own overseas network and partners. The revenue mix by nature (approximation from FY3/26 segment data; company does not disclose a product/service split): *Note: the above split is an analytical characterization; the company does not report revenue by nature.* ### Value-chain position **Agri Business:** fully integrated R&D-type agrochemical originator — chemical synthesis, biological/safety research, formulation research, field evaluation, AI manufacturing (including via Nisso Namhae Agro in Korea) and formulation, registration and global marketing (Stage III plan). The company emphasizes that R&D-type agrochemical originators are largely limited to five overseas majors plus Japanese firms, and that Japanese originators punch above their weight in new AI discovery. **Chemical Materials:** upstream chlor-alkali (caustic soda, chlorine, hydrochloric acid) feeding downstream fine/specialty chemistry (living anionic polymerization for NISSO-PB and VP-POLYMER; cellulose derivatization for HPC; penem API synthesis). **Trading & Logistics:** captive and third-party distribution (Nisso Shoji) and specialized hazardous/pharma logistics (Sanwa Soko, Sanso Unyu). **Engineering:** fine-chemical-type EPC (Nisso Engineering) and civil works (Nisso Kensetsu). **Eco Solutions:** waste treatment, zinc recovery from electric-arc-furnace dust, sulfuric acid recycling (Nisso Metallochemical). ### Customer types and end-markets Customers include global agrochemical majors and distributors, farmers' cooperatives (via channels), generic and innovator pharmaceutical companies and supplement makers (HPC, SSF, faropenem API), copper-clad-laminate (CCL) and semiconductor-materials producers (NISSO-PB, 1,2-SBS, VP-POLYMER), thermal-paper manufacturers (color developers), battery-materials producers, industrial users of commodity chemicals, steelmakers (EAF dust treatment), and public/private construction clients (Engineering). End-markets: crop protection (fruit & vegetables first, expanding to grains), pharmaceuticals/nutraceuticals, semiconductors/electronics (AI servers, HBM, automotive chips), infrastructure, and environmental services. ### Independent characterization Nippon Soda is best understood as two engines and three stabilizers. The engines — Agri Business and specialty Chemical Materials — generated roughly 75% of FY3/26 segment operating profit (JPY 11.2 billion of JPY 14.97 billion before adjustments) on 60% of sales. Agri is cyclical and FX-sensitive (65.7% overseas sales ratio in FY3/26), while Chemical Materials has been structurally re-rated from a ~5–6% margin business to ~15–17% after exiting commodity lines (metallic sodium via Alkaline S.A.S., NISSO HI-CHLON, phenol-based color developers, sodium cyanide). The stabilizers (Trading & Logistics, Engineering, Eco Solutions) are low-growth and modest-margin but add scale and cash. A further, often-overlooked profit pillar is equity-method income (JPY 6.06 billion in FY3/26, chiefly Iharabras in Brazil), which made ordinary profit (JPY 22.99 billion) much larger than operating profit and is highly FX-sensitive (BRL/USD).
RPM International is a holding company for more than a dozen semi-autonomous specialty-chemicals franchises. These businesses make coatings, sealants, roofing, concrete admixtures, flooring, fireproofing and building-envelope systems, mostly for maintenance, repair and restoration rather than new construction. Its brand portfolio is unusually deep for a USD 7.9 billion company: Rust-Oleum, DAP, Zinsser, Varathane and The Pink Stuff on the consumer side; Tremco, Euclid, Dryvit, Nudura, Kalzip, Stonhard, Carboline and Fibergrate on the professional side. Each brand holds a leading position in a niche that larger diversified coatings groups do not dominate. Since 2018 RPM has run successive operational-improvement programs (MAP to Growth, MAP 2025, and now "MAP 3.0"). These have lifted gross margin from about 36% (FY2022) to about 41% (FY2026) and moved the group from a loose federation toward a centrally coordinated operating company. RPM is a disciplined, dividend-growing compounder with 52 consecutive annual dividend increases. Its growth vectors are engineered building systems, emerging markets (the "Platform" model) and bolt-on M&A. --- ### Company's own description (FY2026 Form 10-K, Item 1) RPM describes itself as follows: its subsidiaries manufacture, market and sell specialty chemical product lines, including high-quality specialty paints, infrastructure rehab and repair products, protective coatings, roofing systems, sealants and adhesives. These products focus on the maintenance and improvement needs of the construction, industrial, specialty and consumer markets. Footprint as of 31 May 2026: - Products marketed in about 167 countries and territories. - Manufacturing in about 120 locations across 22 countries. - About 31% of sales generated internationally: foreign operations 29.8% of net sales, plus direct U.S. exports of 0.9%. The press-release boilerplate calls RPM "a world leader in specialty coatings, sealants, building materials and related services." ### Business model RPM's model has four defining features. - **Decentralised entrepreneurial structure, becoming more integrated.** The founder's philosophy, still quoted in the 2026 proxy, is: "Hire the best people you can find. Create an atmosphere that will keep them. Then let them do their jobs." Operating companies historically kept their own brands, sales forces and ERP systems. The MAP programs are deliberately centralising procurement, manufacturing, accounting and IT. The stated goal is to consolidate more than 75 ERP systems to one platform per segment (Q4 FY2026 8-K). **Repair and maintenance bias:** Much of the portfolio serves existing assets: roof restoration, re-cover, concrete repair, corrosion control, rust prevention and DIY touch-up. That demand is less cyclical than new-build construction. The FY2026 10-K notes that re-roofing has historically accounted for over three-quarters of U.S. roofing demand. **Systems and turnkey selling:** In CPG and PCG, RPM increasingly sells integrated systems (the "Power of One" building envelope) and supply-and-apply turnkey services. Examples include Stonhard flooring installation and Weatherproofing Technologies roofing services. This captures more of each construction project's spend. **Bolt-on M&A plus organic growth:** RPM completed six acquisitions in each of FY2025 and FY2026 (FY2026 10-K Note F). ### Revenue model mix | Revenue type | Characterisation | Evidence | |---|---|---| | Product sales | Dominant (estimated well above 90% of revenue; exact split not publicly disclosed) | Manufactured coatings, sealants, admixtures and similar products sold through retail, distribution and direct channels | | Installation and services | Material within CPG and PCG; not separately disclosed | WTI/WTC roofing services, turnkey general contracting, TremCare maintenance programs, Stonhard installed flooring, Legend Brands/RoofTec restoration services, Pure Air Control Services | | Warranty and extended programs | Embedded in pricing; generates deferred revenue | Current unearned revenue USD 75.3M and long-term unearned revenue USD 92.4M at FY2026 (standardized balance sheet) | | Licensing and royalties | Minor | The 10-K notes license fees and royalty income from numerous international license agreements, plus equity-method joint ventures | | Subscription | None identified | — | RPM does not disclose a product versus service versus licensing split. From filings, the mix is: ### Value-chain position RPM is a formulator and brand owner, positioned downstream of commodity chemical producers. It buys petroleum-derived resins, solvents, pigments, minerals, metals and packaging (FY2026 10-K, Raw Materials). It is selectively backward-integrated: RPM cites expanding in-house raw material production, and Arnette Polymers makes amine curing agents and epoxy intermediates. Channels downstream include: - Mass merchants and home centres, where the single largest Consumer customer was 20% of Consumer sales in FY2026. - Hardware and paint stores. - Distributors. - Contractors and specifiers. - Direct sales to industrial plant owners, public institutions and infrastructure agencies. ### Customer types and end markets | End market | Segment exposure | Representative brands | |---|---|---| | Commercial / institutional building envelope (roofing, walls, waterproofing, sealants) | CPG | Tremco, Dryvit, Nudura, illbruck, Kalzip, Volteco | | Concrete, cement and infrastructure | CPG, PCG | Euclid, Toxement, Viapol, Prime Resins, Fibrecrete | | Industrial maintenance, oil and gas, petrochemical, power, data centres | PCG | Carboline, Stonhard, Fibergrate, Nullifire | | Food and pharma | PCG | Mantrose-Haeuser, NatureSeal, Profile Food Ingredients | | Marine, wood finishes, powder coatings | PCG | Pettit, Woolsey, FinishWorks/Mohawk, TCI | | Residential DIY and professional painters | Consumer | Rust-Oleum, Zinsser, Varathane, DAP | | Household cleaning | Consumer | The Pink Stuff, Krud Kutter, Mean Green | | Pigments, colorants, OEM and personal care | Consumer (Color Group) | Day-Glo | | Restoration services equipment | CPG (Legend Brands) | Dri-Eaz, Sapphire Scientific | ### Independent characterisation RPM is best understood as a portfolio of niche category leaders with a structural margin-improvement story layered on top. The professional segments (CPG and PCG) are about 66% of sales and supply the growth. In FY2026 they posted record results driven by high-performance buildings, data centres, infrastructure, fireproofing and concrete admixtures. In Q1 FY2027, emerging-market regions grew more than 20%. The Consumer segment is about 34% of sales. It is a cash-generative but volume-challenged DIY business. Organic Consumer sales fell 0.8% in Q4 FY2026 and 4.7% in Q2 FY2026. They recovered to +5.2% in Q1 FY2027 on shelf-space wins and pricing. The equity debate therefore centres on three questions: 1. Can MAP savings and pricing protect margins against renewed raw-material inflation linked to the Middle East conflict? 2. Is the Q1 FY2027 CPG slowdown temporary? 3. Will the 9 November 2026 investor day credibly frame the next margin plan?
Company Headquarters: Amsterdam, Netherlands Founded: 1994 Workforce: ~35,200 Company Working: Akzo Nobel N.V. operates its business by manufacturing products of various industries such as decorative paints, automotive & specialty coatings, industrial coatings, powder coating and marine, protective and yacht coatings. The automotive and specialty coatings segment of the business comprises products such as aerospace coatings, consumer electronics coatings, automotive OEM coatings, vehicle refinishes and sign finishes. Further, its industrial coatings segment offers products including coil and extrusion coatings, wood finishes, packaging coatings, and adhesives. The company owns more than 3,100 patents and has robust research and development capabilities which is evident from the fact that it has spent around USD 1.33 billion on research and development in last five years and possess five R&D centers. The brand portfolio offered by the company includes Dulux, Sikkens, International and Interpon and has a strong geographical presence in around 150 countries.
Company Headquarters: Ohio, US Founded: 1866 Workforce: ~ 64,000 Company Working: Sherwin Williams Company specializes in the manufacturing of numerous types of paints and coatings products. The company makes its products available through a chain of over 5,000 stores which are operated by the company and through mass merchandisers, independent paint dealers, home centers, automotive retailers, hardware stores, and industrial distributors across various parts of North America, parts of Europe, China, Australia, and New Zealand. The company serves numerous industries such as transportation, construction, and packaging by offering a wide array of product under brands such as Miniwax, Purdy, Carbot and Krylon, among others. Also, it has around 136 manufacturing and distribution facilities across various geographical regions, further enabling the company to expand their market penetration.
Company Headquarters: Tainan City, Taiwan Founded: 1960 Workforce: ~ 5,000 Company Working: CHIMEI, a leading company in the materials and specialty chemicals industry, has a strategic approach focused on innovation, sustainability, and customer-centricity. The company aims to continuously enhance its position by prioritizing research and development efforts, driving technological advancements, and delivering innovative solutions. CHIMEI emphasizes sustainable practices throughout its operations, integrating environmental stewardship into its production processes and product lifecycle management. By minimizing environmental impact and promoting resource efficiency, CHIMEI strives to contribute to a more sustainable future. The company's strategic direction also revolves around understanding and exceeding customer expectations. CHIMEI actively collaborates with customers to comprehend their specific needs and challenges, offering tailored solutions, technical support, and reliable service. Customer satisfaction is a top priority, and CHIMEI's dedication to delivering superior product quality and exceptional customer service sets it apart in the industry.
108 interactive charts drawn from the L-Threonine Market dataset — market size, each segment breakdown, and every region and country by segment. Open one to read its full data table and download it.
Global L-Threonine Market By Region
Global L-Threonine Market By Livestock
Global L-Threonine Market By Physical Form
Global L-Threonine Market — North America by Country
Global L-Threonine Market — North America by Livestock — Market Value
Global L-Threonine Market — North America by Physical Form — Market Value
Global L-Threonine Market — U.S. by Livestock — Market Value
Global L-Threonine Market — U.S. by Physical Form — Market Value
Global L-Threonine Market — Canada by Livestock — Market Value
Global L-Threonine Market — Canada by Physical Form — Market Value
Global L-Threonine Market — Mexico by Livestock — Market Value
Global L-Threonine Market — Mexico by Physical Form — Market Value
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and forecast (2022–2032, USD Million)
Market Size (USD Million)
